Peregrine Pharmaceuticals reported $5.18M in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
AstraZeneca AZN:LN 5509M 2725M
Intrexon XON:US $ -22.07M 10.46M
Minerva Neurosciences NERV:US $ -7.99M 13.39M
Newlink Genetics NLNK:US $ -7.72M 1.16M
Novartis NOVN:VX SF 4214M 623M
Peregrine Pharmaceuticals PPHM:US $ 5.18M 2.76M